Serial T-Spot.Tb and quantiferon-tb-gold in-tube assays to monitor response to antitubercular treatment in italian children with active or latent tuberculosis infection

Pediatric Infectious Disease Journal

Volumn 31, Issue 9, 2012, Pages 974-977

  Chiappini, Elena ^a   Bonsignori, Francesca ^a   Mangone, Giusi ^a   Galli, Luisa ^a   Mazzantini, Rachele ^a   Sollai, Sara ^a   Azzari, Chiara ^a   De Martino, Maurizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

children; interferon release assay; tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; FOLLOW UP; HUMAN; IMMUNOASSAY; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTIFERON-TB GOLD IN-TUBE; QUANTITATIVE ANALYSIS; T-SPOT.TB ASSAY; TREATMENT RESPONSE; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; ITALY; LATENT TUBERCULOSIS; PROSPECTIVE STUDIES; TUBERCULOSIS;

EID: 84865467591     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31825d0d67     Document Type: Article

References (17)

1. Chee CB, KhinMar KW, Gan SH, et al. Tuberculosis treatment effect on T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens. Eur Respir J. 2010;36:355-361.
2. Carrara S, Vincenti D, Petrosillo N, et al. Use of a T cell-based assay for moni-toring efficacy of antituberculosis therapy. Clin Infect Dis. 2004;38:754-756.
3. Sauzullo I, Mengoni F, Lichtner M, et al. In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response. PLoS ONE. 2009;4:e5187.
4. Bosshard V, Roux-Lombard P, Perneger T, et al. Do results of the T-SPOT. TB interferon-gamma release assay change after treatment of tuberculosis? Respir Med. 2009;103:30-34.
5. Kobashi Y, Sugiu T, Ohue Y, et al. Long-term follow-up of the Quan-tiFERON TB-2G test for active tuberculosis disease. Intern Med. 2008;47:1957-1961.
6. Herrmann JL, Belloy M, Porcher R, et al. Temporal dynamics of inter-feron gamma responses in children evaluated for tuberculosis. PLoS ONE. 2009;4:e4130.
7. Nenadic N, Kirin BK, Letoja IZ, et al. Serial interferon-γ release assay in children with latent tuberculosis infection and children with tuberculosis. Pediatr Pulmonol. 2012;47:401-408.
8. Kampmann B, Whittaker E, Williams A, et al. Interferon-gamma release assays do not identify more children with active tuberculosis than the tuber-culin skin test. Eur Respir J. 2009;33:1374-1382.
9. American Academy of Pediatrics. Tuberculosis. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:680-701.
10. Ribeiro S, Dooley K, Hackman J, et al. T-SPOT.TB responses during treat-ment of pulmonary tuberculosis. BMC Infect Dis. 2009;9:23.
11. Dyrhol-Riise AM, Gran G, Wentzel-Larsen T, et al. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country. BMC Infect Dis. 2010;10:57.
12. Lee SH, Lew WJ, Kim HJ, et al. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak. Respir Med. 2010;104:448-453.
13. Lee SW, Lee CT, Yim JJ. Serial interferon-gamma release assays during treat-ment of active tuberculosis in young adults. BMC Infect Dis. 2010;10:300.
14. Bocchino M, Chairadonna P, Matarese A, et al. Limited usefulness of Quan-tiFERON-TB Gold In-Tube for monitoring anti-tuberculosis therapy. Respir Med. 2010;104:1551-1556.
15. Powell DA, Perkins L, Wang SH, et al. Completion of therapy for latent tuberculosis in children of different nationalities. Pediatr Infect Dis J. 2008;27:272-274.
16. Cruz AT, Starke JR. Increasing adherence for latent tuberculosis infection therapy with health department-administered therapy. Pediatr Infect Dis J. 2012;31:193-195.
17. Veerapathran A, Joshi R, Goswami K, et al. T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS ONE. 2008;3:e1850.